Pfizer joins forces with Sinopharm to infiltrate China county hospital market
This article was originally published in Scrip
Executive Summary
Capturing opportunities presented by a new round of China healthcare reforms, Pfizer is revitalizing a nationwide effort, aiming to upgrade cardiovascular disease diagnosis and treatment inside county-level hospitals.